MO stock forecast, quote, news & analysis

Key Takeaways

• Altria Group shares closed at $74.21 on July 17, 2026, approaching the stock's 52-week high of $75.28 and reflecting a gain of approximately 7.6% over the trailing 30-day period.
• The company's Q1 2026 earnings beat consensus estimates, with adjusted EPS of $1.32 on revenue of $4.76 billion, and management issued full-year 2026 EPS guidance of $5.56 to $5.72.
• Altria's smoke-free portfolio strategy and 2028 enterprise goals remain central to its long-term narrative, targeting $5 billion in smoke-free net revenue and at least 35% volume growth from a 2022 base.
• The stock continues to attract income-focused investors, offering a quarterly dividend of $1.06 per share and an annualized yield near 5.7%.
• Analyst sentiment remains mixed, with a consensus "Hold" rating and an average price target of approximately $70.78, though several firms including UBS and Goldman Sachs maintain "Buy" ratings with price targets up to $79.

Current Market Snapshot

Altria Group shares have demonstrated consistent upward momentum through mid-2026, climbing from the mid-$64 range in mid-April to above $74 by mid-July. The stock recently touched a new 52-week high of $75.28 on July 17, reflecting broad investor confidence in the company's earnings trajectory and capital return program. Trading at approximately 15 times forward earnings with a beta of 0.45, MO continues to attract defensive and income-oriented positioning within the consumer staples sector. Institutional ownership stands at 57.41%, with notable accumulation by firms including Vanguard, Charles Schwab Investment Management, and SG Americas Securities during recent quarters. The stock's 200-day moving average sits near $67, well below current trading levels, reinforcing the sustained uptrend.

Altria Group (MO) Business Overview and Competitive Position

Altria Group, headquartered in Richmond, Virginia, is the largest tobacco company in the United States. Its principal operating subsidiaries include Philip Morris USA, the manufacturer of Marlboro cigarettes — the nation's top-selling cigarette brand — as well as John Middleton Co., which produces Black & Mild cigars. In the smoke-free category, Altria owns U.S. Smokeless Tobacco Company (Copenhagen and Skoal brands), Helix Innovations (on! nicotine pouches), and holds exclusive U.S. commercialization rights for the IQOS heated tobacco system. The company also acquired NJOY Holdings in 2023, adding the NJOY ACE e-cigarette brand to its portfolio. Altria's equity investments include a stake in Anheuser-Busch InBev and Cronos Group. With a gross profit margin exceeding 87% and a net margin above 34%, the company's pricing power and brand loyalty remain formidable competitive advantages, even as domestic cigarette consumption gradually declines.

Recent Developments Driving MO

Several catalysts have shaped Altria's stock performance over the past 30 days. The company's Q1 2026 earnings release on April 30 set a positive tone, with revenue of $4.76 billion and adjusted EPS of $1.32 both surpassing Wall Street estimates. Revenue grew 5.3% year-over-year, and the company reaffirmed confidence by issuing full-year 2026 EPS guidance of $5.56 to $5.72. In July, UBS raised its price target on MO to $79 from $76 while maintaining a Buy rating, citing manageable cigarette volume declines, market share gains, and potential EPS growth acceleration into 2027 as pricing investments cycle through. The FDA's recent guidance on enforcement priorities has opened the door for Altria to launch additional on! Plus pouch variants, including 12mg strength and flavored options, and potentially reintroduce NJOY ACE in the vapor segment. On the corporate side, Salvatore Mancuso was elected CEO, and the company announced plans to consolidate U.S. Smokeless Tobacco manufacturing from Nashville into Kentucky by early 2028. Moody's downgraded Altria's senior unsecured rating to Baa2, citing reduced free cash flow tied to litigation-related bonding requirements — a headwind that has not materially derailed the stock's upward trajectory.

Trending AI Robots

For traders and investors seeking data-driven approaches to stock selection, Tickeron's Trending AI Robots page offers a curated view of top-performing AI trading bots actively trading thousands of tickers across global markets. These bots employ diverse strategies spanning different timeframes, asset classes, and risk profiles, allowing users to explore automated trading approaches backed by real-time performance metrics. Only the most relevant and consistently performing bots are featured in this section, helping users quickly identify strategies that align with their trading objectives. Browsing the Trending AI Robots page can serve as a practical starting point for incorporating algorithmic insights into an existing research process.

2026 Outlook and What Investors Should Watch

Altria's Q2 2026 earnings report, expected around July 30, will be the next major catalyst. Analysts forecast EPS of approximately $1.50, up 4.2% from the year-ago period, and investors will closely monitor cigarette shipment volume trends alongside smoke-free product momentum. The company's ongoing expansion of the on! nicotine pouch line and potential FDA authorization milestones remain critical to the 2028 enterprise goals. Macroeconomic factors, including consumer spending patterns and inflation trends, could influence demand for both premium and value-tier tobacco products. Regulatory developments at the FDA — particularly around flavored product authorizations and foreign manufacturer registration requirements — represent an ever-present risk and opportunity set. Additionally, any developments in multi-billion dollar litigation proceedings and associated bonding costs will be monitored for their impact on free cash flow and capital allocation. With the dividend payout ratio at approximately 88.7% and 16 consecutive years of dividend increases, the sustainability of Altria's shareholder return program remains a central focus for long-term investors.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations